Global Biopharmaceutical Processing Equipment & Consumables Market is Anticipated to Cross the USD 110 Billion Mark by 2034 | DelveInsight

The biopharmaceutical processing equipment & consumables market is witnessing robust growth, driven by the rising production of biologics, biosimilars, vaccines, and advanced cell and gene therapies. Increasing investments in biopharmaceutical manufacturing capacity, coupled with the widespread adoption of single-use technologies and automation, are accelerating market expansion. Growing demand for high-quality, scalable, and regulatory-compliant manufacturing solutions is further fueling the adoption of advanced processing equipment and consumables.

LAS VEGAS, July 7, 2026 /PRNewswire/ -- DelveInsight's Biopharmaceutical Processing Equipment & Consumables Market Insights report provides the current and forecast market analysis, individual leading biopharmaceutical processing equipment & consumables companies' market shares, challenges, biopharmaceutical processing equipment & consumables market drivers, barriers, trends, and key biopharmaceutical processing equipment & consumables companies in the market.

Biopharmaceutical Processing Equipment & Consumables Market Summary

• 2025 Biopharmaceutical Processing Equipment & Consumables Market Size: USD 52.1 Billion
• 2034 Projected Biopharmaceutical Processing Equipment & Consumables Market Size: USD 116.4 Billion
• Biopharmaceutical Processing Equipment & Consumables Market Growth Rate (2026-2034): ~9% 
• Largest Biopharmaceutical Processing Equipment & Consumables Market: North America
• Largest Product Type Segment: Filtration Systems Category
• Key Companies in the Biopharmaceutical Processing Equipment & Consumables Market: Thermo Fisher Scientific Inc., Sartorius AG, Cytiva, Merck KGaA, Eppendorf SE, Lonza Group AG, Repligen Corporation, Avantor, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, GEA Group AG, ABEC, Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Entegris, Inc., Saint-Gobain Life Sciences, Parker-Hannifin Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and others

To read more about the latest highlights related to the biopharmaceutical processing equipment & consumables market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/biopharmaceutical-processing-equipment-and-consumables-market

Key Factors Contributing to the Rise in Growth of the Biopharmaceutical Processing Equipment & Consumables Market

• Rising Demand for Biologics and Biosimilars: The increasing adoption of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, and biosimilars has significantly boosted the need for advanced biopharmaceutical processing equipment and single-use consumables. These products require specialized manufacturing systems to ensure high product quality and regulatory compliance.
• Expansion of Biopharmaceutical Manufacturing Capacity: Pharmaceutical companies and contract manufacturers are investing heavily in expanding production facilities to meet the growing global demand for biologics. These capacity expansions are driving purchases of bioreactors, filtration systems, chromatography equipment, and disposable processing components.
• Growing Adoption of Single-Use Technologies: Single-use bioprocessing equipment and consumables are increasingly replacing traditional stainless-steel systems due to their lower contamination risk, reduced cleaning requirements, faster turnaround times, and lower operational costs. This trend is accelerating market growth across both clinical and commercial manufacturing.
• Increasing Investments in Cell and Gene Therapy Production: The rapid development of cell and gene therapies has created demand for specialized processing equipment capable of handling small-batch, high-value biologics. Manufacturers are investing in flexible and scalable technologies to support these advanced therapeutic modalities.
• Expansion of CDMOs: The growing reliance on outsourcing biopharmaceutical manufacturing has fueled investments by CDMOs in state-of-the-art processing infrastructure. Their continuous expansion is driving sustained demand for bioprocess equipment, consumables, and automation solutions.
• Technological Advancements in Bioprocessing: Innovations such as automated bioreactors, continuous bioprocessing, digital monitoring systems, process analytical technologies (PAT), and AI-enabled manufacturing are improving production efficiency, product consistency, and operational flexibility, encouraging equipment upgrades.
• Increasing Vaccine Production and Pandemic Preparedness: Governments and pharmaceutical companies continue to strengthen vaccine manufacturing capabilities to improve preparedness for future infectious disease outbreaks. This has resulted in ongoing investments in upstream and downstream bioprocessing equipment and disposable consumables.
• Stringent Regulatory and Quality Standards: Regulatory agencies require strict compliance with Good Manufacturing Practices (GMP) and quality assurance protocols for biologics manufacturing. This encourages manufacturers to adopt advanced processing systems and high-quality consumables that enhance process reliability and product safety.
• Growing Biopharmaceutical R&D Activities: Rising research investments by pharmaceutical companies, biotechnology firms, and academic institutions are increasing the demand for laboratory-scale and pilot-scale bioprocessing equipment. The transition of drug candidates from research to commercial manufacturing further supports market expansion.

Get a sneak peek at the biopharmaceutical processing equipment & consumables market dynamics @ Biopharmaceutical Processing Equipment & Consumables Market Trends

Regional Biopharmaceutical Processing Equipment & Consumables Market Insights

North America

• North America held the largest share of the biopharmaceutical processing equipment & consumables market, accounting for approximately 38% of global revenue in 2025. 
• The region's leadership is supported by its well-established biopharmaceutical industry, robust manufacturing capabilities, and continuous investments in biologics research, development, and production. 
• The United States, in particular, is home to a large number of biopharmaceutical and biotechnology companies, which represent the primary consumers of bioprocessing equipment and consumables for both clinical development and commercial manufacturing.
• Furthermore, favorable government initiatives promoting biotechnology and biomanufacturing, coupled with the growing demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, are accelerating the expansion of manufacturing capacity across the region. 
• The increasing adoption of advanced technologies such as single-use bioprocessing systems, process automation, and digital manufacturing solutions is further enhancing production efficiency and flexibility. 
• In addition, North America's mature supply chain infrastructure, highly skilled workforce, and strong focus on technological innovation continue to reinforce its dominant position in the global biopharmaceutical processing equipment & consumables market.

Europe

• The European biopharmaceutical processing equipment and consumables market is experiencing steady growth, supported by the region's well-established biopharmaceutical manufacturing industry, rising investments in biologics production, and a favorable regulatory and innovation landscape. 
• Europe hosts several prominent bioprocessing technology providers, including Sartorius AG and Cytiva, alongside a strong network of pharmaceutical companies and contract development and manufacturing organizations (CDMOs) that are expanding their production capacities to address the increasing demand for biologics, vaccines, and advanced therapeutic products. 
• Furthermore, supportive regulatory policies and a growing emphasis on sustainable manufacturing practices and continuous bioprocessing are accelerating the adoption of advanced processing equipment and high-performance consumables. 
• The availability of a highly skilled workforce, robust research and development capabilities, and the increasing outsourcing of biopharmaceutical manufacturing activities continue to strengthen the market's growth trajectory across the region.

Asia-Pacific

• The Asia Pacific region is becoming a key growth hub for the biopharmaceutical processing equipment and consumables market, driven by the rapid expansion of biopharmaceutical manufacturing, rising investments in biotechnology, and increasing demand for biologics and biosimilars. 
• Major economies, including China, India, South Korea, and Japan, are strengthening their domestic biopharmaceutical production capabilities through supportive government policies, favorable regulatory frameworks, and competitive manufacturing costs. 
• The growing presence of contract development and manufacturing organizations (CDMOs), coupled with increased clinical research activities and ongoing improvements in healthcare infrastructure, is fueling the need for advanced bioprocessing equipment and consumables. 
• Furthermore, leading biopharmaceutical manufacturers such as Samsung Biologics and WuXi AppTec continue to invest in large-scale biologics production facilities across the region, enhancing manufacturing capacity, reinforcing supply chains, and driving the adoption of single-use technologies and next-generation bioprocessing solutions. 
• Collectively, these developments are establishing APAC as one of the fastest-growing and most strategically important markets in the global biopharmaceutical processing equipment and consumables industry.

To know more about why North America is leading the market growth in the biopharmaceutical processing equipment & consumables market, get a snapshot of the Biopharmaceutical Processing Equipment & Consumables Market Share

Recent Developmental Activities in the Biopharmaceutical Processing Equipment & Consumables Market

• In February 2026, Sartorius AG announced that it invested approximately EUR 442 million in expanding its bioprocess production capabilities, including facilities in Europe, with a focus on advanced filtration technologies and sustainable solutions.
• In July 2025, Thermo Fisher Scientific acquired a manufacturing site from Sanofi to expand sterile fill-finish capacity, reflecting increasing demand for large-scale biologics production.
• In June 2025, Cytiva expanded its filtration manufacturing capacity in Pensacola, Florida, increasing membrane production by 20% to meet rising demand for bioprocessing filters. 
• In June 2025, Cytiva completed part of its $1.6 billion global investment program, including expansions in the United States to enhance bioprocessing manufacturing capabilities, reflecting strong regional demand for equipment and consumables.
• In June 2025, Cytiva completed major capacity expansions, including significantly increasing chromatography resin production in Uppsala, Sweden, to strengthen regional supply chains and meet rising biologics demand.

What is Biopharmaceutical Processing Equipment & Consumables?

Biopharmaceutical processing equipment and consumables comprise the specialized systems, instruments, and disposable products used throughout the manufacturing of biologic drugs, including monoclonal antibodies, vaccines, cell and gene therapies, recombinant proteins, and other biologics. Processing equipment includes bioreactors, fermenters, filtration systems, chromatography columns, centrifuges, mixers, incubators, and filling and finishing systems that enable upstream and downstream manufacturing operations. Consumables encompass single-use bioprocessing products such as bioreactor bags, tubing, connectors, filters, membranes, culture media, chromatography resins, sampling devices, and sterile containers that come into direct contact with the product during production. Together, these technologies support efficient, scalable, and contamination-controlled manufacturing while ensuring compliance with stringent regulatory and quality standards. The increasing adoption of single-use technologies, process automation, and continuous bioprocessing is further driving innovation in the biopharmaceutical processing equipment and consumables market.

Biopharmaceutical Processing Equipment & Consumables Market Assessment

• Biopharmaceutical Processing Equipment & Consumables Market Segmentation
  • Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Product Type: Equipment (Bioreactors, Filtration Systems, Chromatography Systems, Centrifuges & Separators, and Others) and Consumables
  • Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Workflow Stage: Upstream Processing, Downstream Processing, Formulation & Fill-Finish, and Quality Control & Analytical Testing
  • Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Application: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell & Gene Therapies, and Others
  • Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the biopharmaceutical processing equipment & consumables market are set to emerge as the trendsetter explore @ Biopharmaceutical Processing Equipment & Consumables Market Analysis

Table of Contents 

Interested in knowing the biopharmaceutical processing equipment & consumables market share by 2034? Click to get a snapshot of the Biopharmaceutical Processing Equipment & Consumables Market Size

Related Reports

Single-use Bioreactors Market

Single-use Bioreactors Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key single-use bioreactors companies, including Sartorius AG, Thermo Fisher Scientific Inc., Cytiva, Merck KGaA, Eppendorf SE, ABEC Inc., PBS Biotech Inc., Cellexus International Ltd., Celltainer Biotech BV, Getinge AB, Solaris Biotech Solutions S.r.l., Pierre Guérin SAS, Meissner Filtration Products Inc., Entegris Inc., Avantor Inc., Repligen Corporation, Corning Incorporated, and others.

Pharmaceutical Filtration Market

Pharmaceutical Filtration Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key pharmaceutical filtration companies, including Sartorius AG, Merck KGaA (MilliporeSigma), Pall Corporation, Thermo Fisher Scientific Inc., 3M Company, Meissner Filtration Products, Inc., Porvair Filtration Group Ltd., Donaldson Company, Inc., GVS S.p.A., Eaton Corporation plc, Parker-Hannifin Corporation, Saint-Gobain Life Sciences, Amazon Filters Ltd., Cobetter Filtration Equipment Co., Ltd., Repligen Corporation, GEA Group Aktiengesellschaft, Alfa Laval AB, Asahi Kasei Corporation, Koch Separation Solutions, Sterlitech Corporation, and others.

Upstream Processing Market

Upstream Processing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key upstream processing companies, including Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Eppendorf SE, Lonza Group AG, Corning Incorporated, Avantor, Inc., Getinge AB, Repligen Corporation, FUJIFILM Irvine Scientific, Inc., PBS Biotech, Inc., Hamilton Company, Entegris, Inc., Meissner Filtration Products, Inc., Applikon Biotechnology B.V., Kühner AG, Cellexus International Ltd., GE HealthCare Technologies Inc., AGC Biologics, and others.

Downstream Processing Market

Downstream Processing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key downstream processing companies, including Thermo Fisher Scientific, Merck KGaA, Danaher Corporation (Cytiva), Sartorius AG, Lonza, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us
Shruti Thakur
[email protected]
+14699457679

SOURCE DelveInsight Business Research, LLP